Tuesday, November 24, 2009, 3:25am EST - Canadian Markets open in 6 hours and 5 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Palatin Technologies Inc. (PTN)

On Nov 23: 0.265 USD   0.00 (0.00%)  
MORE ON PTN
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
PALATIN TECH INC (AMEX:PTN) Delayed quote dataEdit
Last Trade: 0.265 USD
Trade Time: Nov 23
Change: 0.00 (0.00%)
Prev Close: 0.265
Open: N/A
Bid: N/A
Ask: N/A
1y Target Est: 1.00
Day's Range: N/A - N/A
52wk Range: 0.06 - 0.48
Volume: 0
Avg Vol (3m): 914,375
Market Cap: 25.49M
P/E (ttm): N/A
EPS (ttm): -0.006
Div & Yield: N/A (N/A%)
Palatin Technologies Inc. (PTN)
1d  5d  3m  6m  1y  2y  5y  max 
 Add PTN to Portfolio   Download Data

HEADLINES
PALATIN TECHNOLOGIES INC Financials
EDGAR Online Financials (Thu, Nov 19)
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
at Seeking Alpha (Mon, Nov 16)
Palatin Technologies Earnings Call scheduled for 11:00 am ET today
CCBN (Mon, Nov 16)
PALATIN TECHNOLOGIES INC Files SEC form 8-K, Results of Operations and Financial Condition
EDGAR Online (Mon, Nov 16)
Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2010 Results; Teleconference and Webcast to be held on November 16, 2009
PRNewswire (Mon, Nov 16)
Q1 2010 Palatin Technologies Earnings Release - 07:30 am ET
CCBN (Mon, Nov 16)
PALATIN TECHNOLOGIES INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Fri, Nov 13)
Palatin Technologies, Inc. To Report Fiscal Year 2010 First Quarter Results; Teleconference and Webcast to be held on November 16, 2009
PRNewswire (Thu, Nov 12)
Palatin Technologies to Present at 8th Annual BIO Investor Forum
PRNewswire (Wed, Oct 28)
PALATIN TECHNOLOGIES INC Files SEC form 8-K, Entry into a Material Definitive Agreement
EDGAR Online (Tue, Sep 29)
More Headlines for PTN...

ANALYST
EPS Est (next year) (Jun-09) : N/A
EPS Est (in 2 years) (Jun-10) : N/A
Avg Rec (current)*: 2.0
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Palatin Technologies, Inc., a biopharmaceutical company, engages in the discovery and development of peptide, peptide mimetic, and small molecule agonist compounds with a focus on melanocortin (MC) and natriuretic peptide receptor systems in the U...

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News Canadian Indices